Patient characteristics
| Characteristic | Patients (N=503) |
| Age (years), median (range) | 70 (38–92) |
| Male sex, n (%) | 403 (80.1) |
| Underlying conditions/procedures, n (%) | |
| Myocardial infarction | 349 (69.4) |
| Angioplasty | 286 (56.9) |
| Coronary artery bypass graft | 192 (38.2) |
| Diabetes* | 62 (12.3) |
| Secondary medicines prescribed, n (%) | |
| Statin | 476 (94.6) |
| Aspirin | 439 (87.3) |
| Beta-blocker | 356 (70.8) |
| ACE inhibitor | 293 (58.3) |
| AIIRA | 104 (20.7) |
| Clopidogrel | 59 (11.7) |
| Total number of medicines†, median (range) | 7 (2–20) |
| Number of individual daily doses, median (range) | 6 (1–24) |
| Number of daily administration times, median (range) | 2 (1–4) |
| Dosing frequency of medicines, n (%) | |
| All once daily | 250 (49.7) |
| At least one medicine taken twice daily‡ | 189 (37.6) |
| At least one medicine taken more than twice daily | 64 (12.7) |
*Prescribed antidiabetic medication.
†Includes all medicines and not just secondary prevention medicines.
‡And no medicines taken more than twice daily.
ACE, angiotensin converting enzyme; AIIRA, angiotensin II receptor antagonists.